Pricing Log in Create free account

Clene Inc. (CLNN) vs Tevogen Inc. (TVGN)

Clene Inc. and Tevogen Inc. are both Biotechnology companies. Clene Inc. and Tevogen Inc. are of similar size ($47.0M and $46.1M). Tevogen Inc. has the higher net margin (0.00% vs −20,059.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Clene Inc. leads on 7 and Tevogen Inc. on 4.

Valuation

Metric CLNN TVGN Biotechnology median
P/E n/m n/m 8.50
P/S 194.86 n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 238.72 n/m 9.21
Earnings yield (112.90%) (87.71%) (33.15%)
Free cash flow yield (41.54%) (42.97%) (25.50%)

Profitability

Metric CLNN TVGN Biotechnology median
Gross margin 70.05% — 65.16%
Operating margin (10,431.98%) 0.00% 0.00%
Net margin (20,059.90%) 0.00% 0.00%
Free cash flow margin (8,095.43%) 0.00% 0.00%
Return on equity 237.15% 123.10% (56.36%)
Return on assets (174.99%) (492.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLNN TVGN Biotechnology median
Revenue growth (TTM) (31.12%) — 6.02%
EPS growth (last fiscal year) 53.26% (72.66%) 30.26%
Revenue growth, 5-year CAGR (0.59%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CLNN TVGN Biotechnology median
Debt to equity (0.74) (0.72) 0.00
Current ratio 3.07 0.33 4.72
Net debt to EBITDA (0.39) (0.15) 0.96

Dividend

Metric CLNN TVGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLNN TVGN Biotechnology median
Market cap 46.98m 46.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack